Related references
Note: Only part of the references are listed.Role of alpha-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease
Qian-Kun Lv et al.
INFLAMMATION RESEARCH (2023)
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
Sephira Ryman et al.
JOURNAL OF NEUROLOGY (2023)
Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson's disease: mechanisms and therapeutic implications
Luca Soraci et al.
JOURNAL OF NEUROLOGY (2023)
a-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to b-Spectrin
Gali Maor et al.
JOURNAL OF NEUROSCIENCE (2023)
Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α-Synuclein
Poul Henning Jensen et al.
MOVEMENT DISORDERS (2023)
Monitoring α-synuclein aggregation
Juan Estaun-Panzano et al.
NEUROBIOLOGY OF DISEASE (2023)
Anti-α-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's disease
Robert Brendza et al.
NEUROBIOLOGY OF DISEASE (2023)
Lecanemab in Early Alzheimer's Disease
Christopher H. van Dyck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Repositioning doxycycline for treating synucleinopathies: Evidence from a pre-clinical mouse model
Pietro La Vitola et al.
PARKINSONISM & RELATED DISORDERS (2023)
α-Synuclein in synaptic function and dysfunction
Manu Sharma et al.
TRENDS IN NEUROSCIENCES (2023)
Alpha-synuclein oligomers alter the spontaneous firing discharge of cultured midbrain neurons
Giulia Tomagra et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2023)
Functional and Pathological Effects of a-Synuclein on Synaptic SNARE Complexes
Virginia Gao et al.
JOURNAL OF MOLECULAR BIOLOGY (2023)
Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
Francesco De Nuccio et al.
BIOMOLECULES (2023)
Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
Ashley N. Brandebura et al.
NATURE REVIEWS NEUROSCIENCE (2023)
Reorganization of the outer layer of a model of the plasma membrane induced by a neuroprotective aminosterol
Beatrice Barletti et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2023)
Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut
Jacqui T. Nimmo et al.
ACTA NEUROPATHOLOGICA (2022)
A study on the interaction of the amyloid fibrils of α-synuclein and hen egg white lysozyme with biological membranes
Ramin Zadali et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2022)
Disease-modifying treatment of Parkinson's disease by phytochemicals: targeting multiple pathogenic factors
Makoto Naoi et al.
JOURNAL OF NEURAL TRANSMISSION (2022)
Implementing Complementary Approaches to Shape the Mechanism of α-Synuclein Oligomerization as a Model of Amyloid Aggregation
Marco Giampa et al.
MOLECULES (2022)
Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease
Chun Chen et al.
MOVEMENT DISORDERS (2022)
Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic
Ryan Limbocker et al.
NATURAL PRODUCT REPORTS (2022)
Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
Hilary Grosso Jasutkar et al.
PHARMACOLOGICAL REVIEWS (2022)
Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein
Jiahong Zhong et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2022)
Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease
Makoto Hideshima et al.
SCIENTIFIC REPORTS (2022)
Binding Stability of Antibody-α-Synuclein Complexes Predicts the Protective Efficacy of Anti-α-synuclein Antibodies
Matthias Hoellerhage et al.
MOLECULAR NEUROBIOLOGY (2022)
A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine
Hui Jing Yu et al.
MOVEMENT DISORDERS (2022)
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity
Simona S. Ghanem et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Inflammatory Animal Models of Parkinson's Disease
Juan Garcia-Revilla et al.
JOURNAL OF PARKINSONS DISEASE (2022)
General Principles Underpinning Amyloid Structure
Alexander I. P. Taylor et al.
FRONTIERS IN NEUROSCIENCE (2022)
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind placebo-controlled phase 1a trial
Johannes Levin et al.
EBIOMEDICINE (2022)
Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches
Marija Vidovic et al.
CELLS (2022)
A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins
Evan Casalino et al.
SLAS DISCOVERY (2022)
Redefining the hypotheses driving Parkinson's diseases research
Sophie L. Farrow et al.
NPJ PARKINSONS DISEASE (2022)
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation
Laura De Luca et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
A penetratin-derived peptide reduces the membrane permeabilization and cell toxicity of ?-synuclein oligomers
Mitra Pirhaghi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Phosphatidylcholine and Phosphatidylserine Uniquely Modify the Secondary Structure of α-Synuclein Oligomers Formed in Their Presence at the Early Stages of Protein Aggregation
Tianyi Dou et al.
ACS CHEMICAL NEUROSCIENCE (2022)
The 3D structure of lipidic fibrils of α-synuclein
Benedikt Frieg et al.
NATURE COMMUNICATIONS (2022)
DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers
Mingyue Jin et al.
NATURE COMMUNICATIONS (2022)
A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology
Jessica Chedid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
How important is the N-terminal acetylation of alpha-synuclein for its function and aggregation into amyloids?
Aditya Iyer et al.
FRONTIERS IN NEUROSCIENCE (2022)
Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model
Mauricio dos Santos Pereira et al.
FRONTIERS IN PHARMACOLOGY (2022)
Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson's disease
Yun Su et al.
JOURNAL OF NEUROLOGY (2022)
Trial of Prasinezumab in Early-Stage Parkinson's Disease
G. Pagano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Trial of Cinpanemab in Early Parkinson's Disease
A. E. Lang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson's disease
Zhong-Ming Ying et al.
ANNALS OF TRANSLATIONAL MEDICINE (2022)
Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement
Gianluigi Forloni et al.
PRION (2022)
Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies
Miriam Hojholt Terkelsen et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson's Disease
Gregory P. Williams et al.
JOURNAL OF PARKINSONS DISEASE (2022)
LRP1 is a neuronal receptor for α-synuclein uptake and spread
Kai Chen et al.
MOLECULAR NEURODEGENERATION (2022)
Lewy Body Disease Primate Model with α-Synuclein Propagation from the Olfactory Bulb
Masanori Sawamura et al.
MOVEMENT DISORDERS (2022)
Structures of α-synuclein filaments from human brains with Lewy pathology
Yang Yang et al.
NATURE (2022)
Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity
Minee L. Choi et al.
NATURE NEUROSCIENCE (2022)
The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
Leif Antonschmidt et al.
NATURE COMMUNICATIONS (2022)
Small soluble α-synuclein aggregates are the toxic species in Parkinson's disease
Derya Emin et al.
NATURE COMMUNICATIONS (2022)
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity
Ines C. Bras et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations
Linh Thi Nhat Nguyen et al.
JOURNAL OF PARKINSONS DISEASE (2022)
Oligomeropathies, inflammation and prion protein binding
Gianluigi Forloni et al.
FRONTIERS IN NEUROSCIENCE (2022)
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease
Hiroaki Sekiya et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Luis Fonseca-Ornelas et al.
NPJ PARKINSONS DISEASE (2022)
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease: A Randomized Controlled Trial
Michael Camilleri et al.
ANNALS OF INTERNAL MEDICINE (2022)
Inflammation promotes synucleinopathy propagation
Tae-Kyung Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson's disease
Hajung Yoo et al.
BMB REPORTS (2022)
Inflammation and immune dysfunction in Parkinson disease
Malu Gamez Tansey et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Rifampicin decreases neuroinflammation to maintain mitochondrial function and calcium homeostasis in rotenone-treated zebrafish
Ilknur Yurtsever et al.
DRUG AND CHEMICAL TOXICOLOGY (2022)
Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models
P. La Vitola et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
Inflammasome activation in neurodegenerative diseases
Kishore Aravind Ravichandran et al.
MOLECULAR MECHANISMS OF NEURODEGENERATION (2021)
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
Ahmed Al-Qassabi et al.
MOVEMENT DISORDERS (2021)
Internalization of α-synuclein oligomers into SH-SY5Y cells
Lindsay J. Shearer et al.
BIOPHYSICAL JOURNAL (2021)
Neuropathology and molecular diagnosis of Synucleinopathies
Shunsuke Koga et al.
MOLECULAR NEURODEGENERATION (2021)
Extract from the Marine Seaweed Padina pavonica Protects Mitochondrial Biomembranes from Damage by Amyloidogenic Peptides
Mario Caruana et al.
MOLECULES (2021)
α-Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC-SNCA Mice
Norihito Uemura et al.
MOVEMENT DISORDERS (2021)
Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy
Sofia Lovestam et al.
FEBS OPEN BIO (2021)
Neurodegenerative Disease and the NLRP3 Inflammasome
Jonathan A. Holbrook et al.
FRONTIERS IN PHARMACOLOGY (2021)
Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models
Jack Wuyang Jin et al.
COMMUNICATIONS BIOLOGY (2021)
Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
Yun Xia et al.
BRAIN (2021)
Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation
Changjing Wang et al.
TRANSLATIONAL NEURODEGENERATION (2021)
Phosphorylated α-synuclein aggregated in Schwann cells exacerbates peripheral neuroinflammation and nerve dysfunction in Parkinson's disease through TLR2/NF-κB pathway
Li Sun et al.
CELL DEATH DISCOVERY (2021)
Doxycycline inhibits α -synuclein-associated pathologies in vitro and in vivo
Antonio Dominguez-Meijide et al.
NEUROBIOLOGY OF DISEASE (2021)
Rifampicin ameliorates lipopolysaccharide-induced cognitive and motor impairments via inhibition of the TLR4/MyD88/NF-κB signaling pathway in mice
Wei Bi et al.
NEUROLOGICAL RESEARCH (2021)
The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
Roberta Cascella et al.
NATURE COMMUNICATIONS (2021)
Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation
Blagovesta Popova et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
The Anti-Inflammatory Properties of Phytochemicals and Their Effects on Epigenetic Mechanisms Involved in TLR4/NF-κB-Mediated Inflammation
Haidy A. Saleh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Astrocytic atrophy as a pathological feature of Parkinson's disease with LRRK2 mutation
Paula Ramos-Gonzalez et al.
NPJ PARKINSONS DISEASE (2021)
Exploring the Release of Toxic Oligomers from α-Synuclein Fibrils with Antibodies and STED Microscopy
Alessandra Bigi et al.
LIFE-BASEL (2021)
Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
Tomohiro Umeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies
Hannah Scheiblich et al.
JOURNAL OF IMMUNOLOGY (2021)
Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease
Hengxing Zheng et al.
NEUROSCIENCE (2021)
Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo
Debashis Dutta et al.
NATURE COMMUNICATIONS (2021)
Vagus Nerve and Stomach Synucleinopathy in Parkinson's Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the Body-First Hypothesis
Thomas G. Beach et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study
Werner Poewe et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
Ryan Limbocker et al.
FRONTIERS IN NEUROSCIENCE (2021)
Conformation-specific perturbation of membrane dynamics by structurally distinct oligomers of Alzheimer's amyloid-β peptide
Priyanka Madhu et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
N-Terminal Ubiquitination of Amyloidogenic Proteins Triggers Removal of Their Oligomers by the Proteasome Holoenzyme
Yu Ye et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease
Md Ezazul Haque et al.
MOVEMENT DISORDERS (2020)
PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins
Grant T. Corbett et al.
ACTA NEUROPATHOLOGICA (2020)
alpha-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model
Tomoyuki Taguchi et al.
BRAIN (2020)
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease
Ruwani S. Wijeyekoon et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Rifampicin attenuates rotenone-treated microglia inflammation via improving lysosomal function
Yanran Liang et al.
TOXICOLOGY IN VITRO (2020)
Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy
Xue-Jing Wang et al.
NATURE COMMUNICATIONS (2020)
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
Marie-Laure Arotcarena et al.
BRAIN (2020)
Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson's disease familial A53T mutation
Yunpeng Sun et al.
CELL RESEARCH (2020)
Inhibition of synucleinopathic seeding by rationally designed inhibitors
Smriti Sangwan et al.
ELIFE (2020)
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
Carolina Pellegrini et al.
PROGRESS IN NEUROBIOLOGY (2020)
Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure
Kun Zhao et al.
NATURE COMMUNICATIONS (2020)
Microglia clear neuron-released a-synuclein via selective autophagy and prevent neurodegeneration
Insup Choi et al.
NATURE COMMUNICATIONS (2020)
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Junling Yang et al.
FRONTIERS IN IMMUNOLOGY (2020)
P2X7 Receptor is Involved in Mitochondrial Dysfunction Induced by Extracellular Alpha Synuclein in Neuroblastoma SH-SY5Y Cells
Anna Wilkaniec et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo
Qihui Wu et al.
ACTA NEUROPATHOLOGICA (2020)
Parkinson's disease: etiopathogenesis and treatment
Joseph Jankovic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Safety and immunogenicity of the α-synuclein active immunotherapeutic PDO1A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
Dieter Volc et al.
LANCET NEUROLOGY (2020)
SUMOylation in alpha-Synuclein Homeostasis and Pathology
Mor Savyon et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Fibrillar α-synuclein toxicity depends on functional lysosomes
Stephanie J. Guiney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
A Phase 1 Randomized Trial of Specific Activeα-SynucleinImmunotherapiesPD01AandPD03Ain Multiple System Atrophy
Wassilios G. Meissner et al.
MOVEMENT DISORDERS (2020)
Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease
Christine L. West et al.
JOURNAL OF PARKINSONS DISEASE (2020)
Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
Miguel Lemos et al.
TRANSLATIONAL NEURODEGENERATION (2020)
α-Synuclein Exhibits Differential Membrane Perturbation, Nucleation, and TLR2 Binding through Its Secondary Structure
Manisha Kumari et al.
ACS CHEMICAL NEUROSCIENCE (2020)
The Role of α-Synuclein Oligomers in Parkinson's Disease
Xiao-yu Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-Synuclein
Richard M. Meade et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
Jacqui T. Nimmo et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Alzheimer's disease: from basic science to precision medicine approach
Gianluigi Forloni
BMJ NEUROLOGY OPEN (2020)
Sequence and structure-based peptides as potent amyloid inhibitors: A review
Amit Mitra et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
Laura Boi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease
Chrysoula Marogianni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration
Valentina Durante et al.
BRAIN (2019)
α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons
Qihui Wu et al.
JOURNAL OF NEUROSCIENCE (2019)
Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models
Andreas Weihofen et al.
NEUROBIOLOGY OF DISEASE (2019)
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice
Yuki Kishimoto et al.
NEUROMOLECULAR MEDICINE (2019)
Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases
Wenjuan Zhang et al.
ELIFE (2019)
Identification of a New α-Synuclein Aggregation Inhibitor via Mass Spectrometry Based Screening
Mingming Xu et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model
Michal Wegrzynowici et al.
ACTA NEUROPATHOLOGICA (2019)
Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats
Nathalie Van Den Berge et al.
ACTA NEUROPATHOLOGICA (2019)
Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies
Antonina Kouli et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054
Miroslaw Brys et al.
MOVEMENT DISORDERS (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
Claudia Balducci et al.
FRONTIERS IN PHARMACOLOGY (2019)
Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates
Leonardo Acuna et al.
CELLS (2019)
N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism
Matthew D. Watson et al.
BIOCHEMISTRY (2019)
α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities
Parvez Alam et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders
Gunnar R. Leitner et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs
David R. Boyer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons
Goutham K. Ganjam et al.
CELL DEATH & DISEASE (2019)
Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease?
Milica Cerovic et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
Somin Kwon et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects
Pietro La Vitola et al.
BRAIN (2019)
Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice
Jacopo Lucchetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
Antonio Heras-Garvin et al.
MOVEMENT DISORDERS (2019)
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo
Darren J. Schofield et al.
NEUROBIOLOGY OF DISEASE (2019)
Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation
Hiroaki Sekiya et al.
ACTA NEUROPATHOLOGICA (2019)
On the ubiquity of helical α-synuclein tetramers
Liang Xu et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)
Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease
Guilherme A. P. de Oliveira et al.
COMMUNICATIONS BIOLOGY (2019)
Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA
Katarzyna Kuter et al.
MOLECULAR NEUROBIOLOGY (2018)
Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine
Michele Perni et al.
ACS CHEMICAL BIOLOGY (2018)
Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2
Pietro La Vitola et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Alzheimer's Disease, Oligomers, and Inflammation
Gianluigi Forloni et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Intercellular transfer of pathogenic alpha-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal
Shi Zhang et al.
NEUROBIOLOGY OF AGING (2018)
Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models
Claudia Balducci et al.
NEUROBIOLOGY OF AGING (2018)
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
Fredric P. Manfredsson et al.
NEUROBIOLOGY OF DISEASE (2018)
α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton
Dalila G. Ordonez et al.
NEURON (2018)
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
Iryna Prots et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Therapeutic role of rifampicin in Alzheimer's disease
Burak Yulug et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Cryo-EM structure of alpha-synuclein fibrils
Ricardo Guerrero-Ferreira et al.
ELIFE (2018)
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease A Randomized Clinical Trial
Joseph Jankovic et al.
JAMA NEUROLOGY (2018)
Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease
Mariza Bortolanza et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
Changyoun Kim et al.
MOLECULAR NEURODEGENERATION (2018)
Secretion and Uptake of -Synuclein Via Extracellular Vesicles in Cultured Cells
Gabriel Gustafsson et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
Richard Gordon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies
Maria Graciela Cersosimo
CELL AND TISSUE RESEARCH (2018)
Spread of aggregates after olfactory bulb injection of alpha-synuclein fibrils is associated with early neuronal loss and is reduced long term
Nolwen L. Rey et al.
ACTA NEUROPATHOLOGICA (2018)
First-in-human assessment of PRX002, an anti--synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk et al.
MOVEMENT DISORDERS (2017)
High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors
Jordi Pujols et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy
Serena Venezia et al.
MOLECULAR NEURODEGENERATION (2017)
α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B
Diana G. Ferreira et al.
NATURE NEUROSCIENCE (2017)
A role of BAG3 in regulating SNCA/α-synuclein clearance via selective macroautophagy
Yu-Lan Cao et al.
NEUROBIOLOGY OF AGING (2017)
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
Michele Perni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells
Anna Wilkaniec et al.
PURINERGIC SIGNALLING (2017)
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
Giuliana Fusco et al.
SCIENCE (2017)
Investigation of Endocytic Pathways for the Internalization of Exosome-Associated Oligomeric Alpha-Synuclein
Marion Delenclos et al.
FRONTIERS IN NEUROSCIENCE (2017)
Repurposing doxycycline for synucleinopathies: remodelling of α-synuclein oligomers towards non-oxic parallel beta-sheet structured species
Florencia Gonzalez-Lizarraga et al.
SCIENTIFIC REPORTS (2017)
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies
Marti Colom-Cadena et al.
BRAIN (2017)
Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice
Juliana T. S. Fortuna et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production
Victor Tapias et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
Hugo Vicente Miranda et al.
BRAIN (2017)
Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease
Claudia Balducci et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes
Corinna Bliederhaeuser et al.
ACTA NEUROPATHOLOGICA (2016)
Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease
Nolwen L. Rey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Staphylococcal LTA-Induced miR-143 Inhibits Propionibacterium acnes-Mediated Inflammatory Response in Skin
Xiaoli Xia et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
Caroline H. Williams-Gray et al.
MOVEMENT DISORDERS (2016)
Oligomeropathies and Pathogenesis of Alzheimer and Parkinson's Diseases
Gianluigi Forloni et al.
MOVEMENT DISORDERS (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Interventional trials in atypical parkinsonism
S. Eschlboeck et al.
PARKINSONISM & RELATED DISORDERS (2016)
Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
Lisa Fellner et al.
FRONTIERS IN NEUROSCIENCE (2016)
Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
Adelin Gustot et al.
BIOCHEMICAL JOURNAL (2015)
Optimizing clinical trial design for multiple system atrophy: lessons from the rifampicin study
Wolfgang Singer et al.
CLINICAL AUTONOMIC RESEARCH (2015)
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
W. Peelaerts et al.
NATURE (2015)
Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases
Gianluigi Forloni et al.
PRION (2015)
KTKEGV repeat motifs are key mediators of normal α-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity
Ulf Dettmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
Ulf Dettmer et al.
NATURE COMMUNICATIONS (2015)
Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
Changyoun Kim et al.
CELL REPORTS (2015)
Olfactory Dysfunction and Neurotransmitter Disturbance in Olfactory Bulb of Transgenic Mice Expressing Human A53T Mutant α-Synuclein
Sufang Zhang et al.
PLOS ONE (2015)
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Staffan Holmqvist et al.
ACTA NEUROPATHOLOGICA (2014)
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
Johannes Levin et al.
ACTA NEUROPATHOLOGICA (2014)
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials
Markus Mandler et al.
ACTA NEUROPATHOLOGICA (2014)
Defined α-synuclein prion-like molecular assemblies spreading in cell culture
Suzana Aulic et al.
BMC NEUROSCIENCE (2014)
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
Edward Rockenstein et al.
BRAIN (2014)
In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
Claudia Balducci et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
α-Synuclein oligomers distinctively permeabilize complex model membranes
Anja N. D. Stefanovic et al.
FEBS JOURNAL (2014)
Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca2+-induced Mitochondrial Dysfunction
Eric S. Luth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration
Karen Rosenberger et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
Stephane Haik et al.
LANCET NEUROLOGY (2014)
Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates
Laura A. Volpicelli-Daley et al.
NATURE PROTOCOLS (2014)
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Giuliana Fusco et al.
NATURE COMMUNICATIONS (2014)
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2013)
Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
Angelique Camilleri et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Membrane Remodeling by α-Synuclein and Effects on Amyloid Formation
Zhiping Jiang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
α-Synuclein Oligomers: an Amyloid Pore?
Martin T. Stckl et al.
MOLECULAR NEUROBIOLOGY (2013)
Properties of native brain α-synuclein
Jacqueline Burre et al.
NATURE (2013)
Colonic inflammation in Parkinson's disease
David Devos et al.
NEUROBIOLOGY OF DISEASE (2013)
Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
Changyoun Kim et al.
NATURE COMMUNICATIONS (2013)
Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure
Maria Soledad Celej et al.
BIOCHEMICAL JOURNAL (2012)
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Nunilo Cremades et al.
CELL (2012)
Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
Tobias R. Kollmann et al.
IMMUNITY (2012)
a-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
Zane S. Martin et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Karin M. Danzer et al.
MOLECULAR NEURODEGENERATION (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
Wei Bi et al.
BRAIN RESEARCH (2011)
Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein
Ken Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prion propagation and toxicity in vivo occur in two distinct mechanistic phases
Malin K. Sandberg et al.
NATURE (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
A soluble α-synuclein construct forms a dynamic tetramer
Wei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival
Evangelia Emmanouilidou et al.
JOURNAL OF NEUROSCIENCE (2010)
Ribosylation Rapidly Induces α-Synuclein to Form Highly Cytotoxic Molten Globules of Advanced Glycation End Products
Lan Chen et al.
PLOS ONE (2010)
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Claudia Balducci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein
Franz Marxreiter et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology
Karin M. Danzer et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Structural Properties of Pore-Forming Oligomers of α-Synuclein
Hai-Young Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
Kelvin C. Luk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
Laura Parkkinen et al.
ACTA NEUROPATHOLOGICA (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower et al.
NATURE MEDICINE (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia
Seija Lehnardt et al.
JOURNAL OF IMMUNOLOGY (2006)
Small molecule inhibitors of α-synuclein filament assembly
Masami Masuda et al.
BIOCHEMISTRY (2006)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
α-Synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy
KE Paleologou et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Protective effect of TAT-delivered α-synuclein:: relevance of the C-terminal domain and involvement of HSP70
D Albani et al.
FASEB JOURNAL (2004)
Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases
R Kayed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients
R Bahadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Pharmacological prevention of Parkinson disease in Drosophila
PK Auluck et al.
NATURE MEDICINE (2002)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Tetracyclines affect prion infectivity
G Forloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory β-synuclein-derived peptides
M Windisch et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Neurodegenerative disease - Amyloid pores from pathogenic mutations
HA Lashuel et al.
NATURE (2002)
Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease
J Xu et al.
NATURE MEDICINE (2002)
Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease
PK Auluck et al.
SCIENCE (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form
HJ Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Alpha-synuclein and Parkinson's disease
CB Lücking et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro
F Tagliavini et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
R Borghi et al.
NEUROSCIENCE LETTERS (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides
C Soto et al.
LANCET (2000)